07 Nov '22
SAN JOSE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the filing of Eargo’s Quarterly Report on Form 10-Q for the quarterly period
03 Nov '22
Third Quarter 2022 Highlights: Net revenues of $7.9 million, compared to ($22.9) million in the prior year period Gross systems shipped of 5,156, compared to 13,117 in the prior year period Return accrual rate of 32.3%, compared to 46.4% in the prior year period GAAP gross margin of 24.0%; non-GAAP
31 Oct '22
SAN JOSE, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that it has commenced a rights offering for up to 375 million newly issued
Displaying 1 - 10 of 26